CEACAM5
Basic information
Region (hg38): 19:41708585-41730433
Previous symbols: [ "CEA" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CEACAM5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 42 | 10 | 58 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 42 | 7 | 16 |
Variants in CEACAM5
This is a list of pathogenic ClinVar variants found in the CEACAM5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-41708770-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
19-41709692-C-A | not specified | Uncertain significance (Oct 26, 2022) | ||
19-41709719-A-G | not specified | Uncertain significance (Aug 19, 2021) | ||
19-41709721-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
19-41709737-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
19-41709746-A-C | not specified | Uncertain significance (Mar 11, 2025) | ||
19-41709768-G-T | Benign (Dec 28, 2017) | |||
19-41709774-A-C | Benign (Dec 28, 2017) | |||
19-41709825-T-C | Benign (Dec 31, 2019) | |||
19-41709842-A-C | not specified | Uncertain significance (Oct 17, 2024) | ||
19-41709853-A-G | Benign (Dec 31, 2019) | |||
19-41709854-T-C | not specified | Uncertain significance (Dec 05, 2024) | ||
19-41709863-T-C | Benign (Dec 31, 2019) | |||
19-41709878-A-C | not specified | Uncertain significance (Mar 19, 2024) | ||
19-41709886-C-T | not specified | Uncertain significance (Jan 03, 2025) | ||
19-41709901-A-G | not specified | Uncertain significance (Dec 26, 2023) | ||
19-41709911-A-G | not specified | Uncertain significance (Dec 26, 2023) | ||
19-41709914-T-C | Benign (Dec 31, 2019) | |||
19-41709922-C-T | Benign (May 08, 2018) | |||
19-41709949-A-G | Benign (Dec 31, 2019) | |||
19-41709953-T-C | Benign (Dec 31, 2019) | |||
19-41710011-A-T | not specified | Uncertain significance (Mar 11, 2025) | ||
19-41714991-A-G | not specified | Uncertain significance (Feb 12, 2025) | ||
19-41715006-T-G | not specified | Uncertain significance (Mar 04, 2024) | ||
19-41715015-G-A | not specified | Uncertain significance (Nov 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CEACAM5 | protein_coding | protein_coding | ENST00000221992 | 9 | 21215 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.16e-10 | 0.792 | 125691 | 0 | 56 | 125747 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.186 | 370 | 380 | 0.973 | 0.0000210 | 4543 |
Missense in Polyphen | 104 | 115.81 | 0.89802 | 1598 | ||
Synonymous | -2.18 | 196 | 161 | 1.22 | 0.00000971 | 1449 |
Loss of Function | 1.61 | 19 | 28.2 | 0.674 | 0.00000140 | 313 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000648 | 0.0000615 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00144 | 0.00144 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:2803308, PubMed:10910050, PubMed:10864933). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050). {ECO:0000269|PubMed:10864933, ECO:0000269|PubMed:10910050, ECO:0000269|PubMed:2803308}.;
- Pathway
- Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins;Cell surface interactions at the vascular wall;Hemostasis
(Consensus)
Intolerance Scores
- loftool
- 0.746
- rvis_EVS
- 1.92
- rvis_percentile_EVS
- 97.44
Haploinsufficiency Scores
- pHI
- 0.0483
- hipred
- N
- hipred_score
- 0.194
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.250
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- apoptotic process;homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;negative regulation of myotube differentiation;homotypic cell-cell adhesion;negative regulation of apoptotic process;leukocyte migration;negative regulation of anoikis
- Cellular component
- extracellular region;plasma membrane;integral component of plasma membrane;cell surface;basolateral plasma membrane;apical plasma membrane;anchored component of membrane;extracellular exosome;integral component of external side of plasma membrane
- Molecular function
- GPI anchor binding;identical protein binding;protein homodimerization activity